by Chris Black
There is no easy multibillion dollar profit to be made off readily available generic drugs. So Merck will get the approval to market a cancer causing worthless drug, because they can charge $700 for a treatment instead of the $2.75 Ivermectin costs.
There is no such thing as healthcare.
Only murder for profit.
Merck To Double Production Of 'Breakthrough' COVID Drug As Nations Line Up To Buy t.co/KSS2nPzp7K
— zerohedge (@zerohedge) October 12, 2021
Views: